Back
Insmed 10K Form
Sell
41
INSM
Insmed
Last Price:
$67.76
Seasonality Move:
7.06%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-09 | 10Q | INSM/Insmed Quarterly |
2023-10-26 | 10Q | INSM/Insmed Quarterly |
2023-08-03 | 10Q | INSM/Insmed Quarterly |
2023-05-04 | 10Q | INSM/Insmed Quarterly |
2022-10-27 | 10Q | INSM/Insmed Quarterly |
2022-08-04 | 10Q | INSM/Insmed Quarterly |
Receive INSM News And Ratings
See the #1 stock for the next 7 days that we like better than INSM
INSM Financial Statistics
Sales & Book Value
Annual Sales: | $363.7M |
---|---|
Cash Flow: | $-272.2M |
Price / Cash Flow: | 0 |
Annual Sales: | $0.55 |
Price / Book: | 119.38 |
Profitability
EPS (TTM): | -5.95000 |
---|---|
Net Income (TTM): | $-1B |
Gross Margin: | $278M |
Return on Equity: | -1146.32% |
Return on Assets: | -57.25% |
Insmed Earnings Forecast
Key Insmed Financial Ratios
-
The Gross Profit Margin over the past 26 years for INSM is 76.43%.
-
The Selling, General & Administrative Expenses for INSM have been equal to 126.78% of Gross Profit Margin.
-
The Research & Development expenses have been 164.52% of Revenue.
-
The Net Earning history of INSM is -251.24% of Total Revenues.
-
Per Share Earnings over the last 26 years have been positive in 9 years.
Insmed Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Biotechnology |
Sector: | Health Care |
Current Symbol: | INSM |
CUSIP: | 457669 |
Website: | insmed.com |
Debt
Debt-to-Equity Ratio: | 11.14 |
---|---|
Current Ratio: | 5.86 |
Quick Ratio: | 5.21 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |